Mad Money' host Jim Cramer looks at several healthcare stocks and shares his perspective on their trajectory in 2025.
Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent ...
Stocks in Focus This Week. In this article, we are going to take a look at where Wells Fargo & Company (NYSE:WFC) stands ...
Stocks in Focus This Week. In this article, we are going to take a look at where Schlumberger Limited (NYSE:SLB) stands ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Honeywell International is considering splitting into two companies. Jim Cramer is bullish on the company's plans to break up ...
CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...
Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.
Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.
MasterChef champion Simon Wood has taken aim at diners who leave "harsh" reviews. Meanwhile, borrowers are being urged to secure a mortgage deal quickly amid concern swap rates could rise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback